Introduction: The Growing Threat of Pharmaceutical Waste

Pharmaceutical residues in wastewater have emerged as a critical environmental concern. Over 4,000 active pharmaceutical ingredients (APIs) are sold globally, and a significant fraction of every dose is excreted unchanged or as active metabolites. Conventional municipal wastewater treatment plants were never designed to remove these complex organic molecules, resulting in continuous discharge of drugs such as antibiotics, analgesics, hormones, and antidepressants into rivers, lakes, and groundwater. This contamination disrupts aquatic ecosystems, contributes to antimicrobial resistance, and can even pass into drinking water supplies at trace levels. Chemical treatment methods offer the most direct and scalable approach to breaking down or capturing these pollutants before they reach the environment.

Understanding the Chemical Challenge

Pharmaceuticals are intentionally designed to be stable and biologically active. Their molecular structures include aromatic rings, halogens, and polar functional groups that resist natural degradation. Some compounds, such as carbamazepine and diclofenac, are highly persistent, with half-lives measured in years in water. Chemical techniques exploit powerful reagents or chemical interactions to either destroy the drug molecule via redox reactions or bind it to a solid phase for removal. The choice of method depends on the target pharmaceuticals, matrix complexity, and treatment objectives.

Advanced Oxidation Processes (AOPs): The Gold Standard

Advanced oxidation processes are among the most studied and effective chemical techniques for pharmaceutical removal. AOPs generate highly reactive hydroxyl radicals (•OH), which non-selectively attack organic molecules at rates near diffusion-limited (k ≈ 10⁹ M⁻¹ s⁻¹). This allows them to degrade even the most recalcitrant APIs into smaller, less harmful intermediates, and ultimately mineralize them to CO₂, water, and inorganic ions.

Ozonation

Ozone (O₃) is a strong oxidant (E° = 2.07 V) applied directly to wastewater. It reacts preferentially with unsaturated bonds and aromatic systems. Many pharmaceuticals, including sulfamethoxazole, 17α-ethinylestradiol, and ibuprofen, are rapidly oxidized by ozone. The main limitation is that ozone reacts more slowly with saturated structures, and partial oxidation can produce more toxic by-products if not fully mineralized. Combining ozone with hydrogen peroxide (O₃/H₂O₂) or UV light enhances hydroxyl radical generation and broadens the reactivity spectrum.

Fenton and Photo-Fenton Processes

The Fenton reaction uses ferrous iron (Fe²⁺) and hydrogen peroxide (H₂O₂) to produce hydroxyl radicals at acidic pH (2–4). It is highly effective for degrading many pharmaceuticals but requires pH adjustment and produces iron sludge that must be managed. The photo-Fenton variant adds UV or visible light to regenerate Fe²⁺ and increase radical production, improving efficiency and reducing sludge. Process optimization can achieve >90% removal of APIs such as amoxicillin, paracetamol, and ciprofloxacin within minutes.

Heterogeneous Photocatalysis (TiO₂/UV)

Using semiconductor photocatalysts like titanium dioxide (TiO₂) irradiated with UV light generates electron–hole pairs that produce both hydroxyl radicals and superoxide anions. This method works at near-neutral pH, does not consume chemicals, and can be reused after separation. Photocatalysis effectively degrades a wide range of pharmaceuticals, including diclofenac, metoprolol, and trimethoprim. Practical challenges include catalyst recovery and UV penetration in turbid wastewater.

Electrochemical Oxidation

Applying an electric current to electrodes (e.g., boron-doped diamond, mixed metal oxides) generates strong oxidants such as hydroxyl radicals, chlorine radicals, and active chlorine at the anode surface. Electrochemical oxidation is versatile, requires no added chemicals, and can achieve total organic carbon (TOC) reduction. It is especially suitable for industrial wastewater high in pharmaceutical content, but energy consumption is a consideration for large-scale application.

Adsorption and Chemical Binding Techniques

Adsorption physically transfers pharmaceuticals from the liquid phase to a solid adsorbent surface. Chemical modifications or chemical regeneration enhance binding capacity and selectivity.

Activated Carbon (AC)

Granular or powdered activated carbon is the most widely used adsorbent in advanced wastewater treatment. High surface area (800–1,200 m²/g) and porous structure allow AC to capture a broad range of hydrophobic pharmaceuticals. Chemical activation with KOH or H₃PO₄ during carbon production improves pore volume and surface functional groups. Regeneration methods—thermal, chemical (e.g., acid/base washes), or electrochemical—restore capacity but can produce secondary waste. AC is effective against steroids, antibiotics, and beta-blockers at typical doses of 10–50 mg/L.

Ion Exchange and Chelating Resins

Pharmaceuticals with ionizable groups—like quaternary amines in antibiotics or carboxylates in NSAIDs—can be removed by ion-exchange resins. Cation-exchange resins capture positively charged species; anion-exchange resins capture negative ones. Chelating resins with immobilized ligands (e.g., iminodiacetic acid) selectively bind metal-containing drugs, such as cisplatin-derived platinum residues from oncology hospital wastewater. Chemical elution with high-ionic-strength solutions regenerates the resins for reuse.

Chemical Coagulation and Flocculation

Adding metal salts (alum, ferric chloride) or organic polymers causes colloidal particles and dissolved organic matter to aggregate into flocs that settle or filter out. This method partially removes pharmaceuticals associated with suspended solids or organic matter, but removal of dissolved, non-adsorbed APIs is low (typically <20–30%). Coagulation is best used as a pre-treatment before AOPs or membrane filtration to reduce the organic load.

Chemical By-Products and Environmental Safety

Chemical oxidation rarely achieves complete mineralisation. Reaction intermediates often retain some biological activity and can be more toxic than the parent compound. For example, ozonation of diclofenac can form chlorinated quinones, while Fenton oxidation of sulfonamides may produce sulfanilic acid derivatives. Thorough toxicity testing using bioassays (e.g., Vibrio fischeri, fish embryo tests) is essential to verify that treated effluent is safe for discharge. Chemical disinfection by-products like bromate (from ozone with bromide-rich water) and nitrosamines also require monitoring and control. Process engineers must balance removal efficiency with the formation of persistent or toxic by-products, often by combining chemical steps with biological post-treatment.

Case Studies and Real-World Applications

Hospital Wastewater Treatment

Hospitals are point sources of pharmaceutical pollution, discharging high concentrations of antibiotics, contrast agents, and cytostatics. A study at a German hospital using a combined ozone–activated carbon system achieved >95% removal of 15 target pharmaceuticals, including ciprofloxacin, metronidazole, and cyclophosphamide. The system included a pre-filter, ozone contact chamber, and granular activated carbon filtration. Operational costs were approximately €0.20 per m³ treated.

Municipal Wastewater Polishing

Several Swiss wastewater treatment plants (a country that banned untreated pharmaceutical discharge) have implemented ozonation plus sand filtration. For example, the Werdhölzli plant in Zurich uses 0.5–1.5 mg O₃/mg DOC, achieving 80% reduction of micropollutants with an overall energy demand of 0.3 kWh/m³. The treated effluent meets Swiss water quality criteria, demonstrating the feasibility of large-scale chemical treatment.

Integration with Biological and Membrane Processes

Chemical techniques rarely stand alone. The most resilient and cost-efficient systems combine chemical pre-treatment with biological degradation (e.g., activated sludge, moving bed bioreactors) and physical separation (ultrafiltration, reverse osmosis). Hybrid processes such as ozonation-biological activated carbon (O₃/BAC) use ozone to partially oxidize pharmaceuticals, making them more biodegradable, then remove remaining compounds and by-products biologically. This reduces chemical dose and sludge generation compared to standalone AOPs.

Membrane bioreactors (MBRs) coupled with advanced oxidation (e.g., UV/H₂O₂/O₃) can produce high-quality effluent suitable for water reuse. The membrane retains particulate matter and some high-molecular-weight pharmaceuticals, while chemical oxidation polishes the low-molecular-weight fraction. Such systems are already deployed in industrial and decentralized reuse schemes.

Economic and Operational Considerations

Chemical treatment cost depends on chemical consumption, energy use, sludge/disposal, and capital equipment. Ozonation typically costs $0.05–0.30/m³; AOPs like UV/H₂O₂ can cost $0.10–0.50/m³; adsorption on activated carbon adds $0.01–0.10/m³ for material and regeneration. For a medium-sized plant treating 10,000 m³/day, annual chemical costs alone can reach $200,000–500,000. Optimization through adaptive dosing (based on real-time UV/Vis or fluorescence sensors) can reduce chemical waste and operating expenses.

Operational challenges include scaling of oxidant delivery, pH control, quenching of residual oxidants (e.g., sodium bisulfite), and management of reaction by-products. Automated process control systems are increasingly used to maintain optimal conditions.

Future Directions and Research Frontiers

Electro-Fenton and Solar-Driven Processes

Electro-Fenton generates H₂O₂ in situ at the cathode while regenerating Fe²⁺, avoiding external chemical dosing. Solar photocatalytic reactors using TiO₂, BiVO₄, or new metal–organic frameworks (MOFs) can harness sunlight to drive AOPs, reducing energy costs. Recent work at the University of Barcelona demonstrated 90% removal of sulfamethazine with a solar photo-Fenton system treating 100 L in a raceway pond reactor.

Catalytic Wet Air Oxidation (CWAO)

Using a heterogeneous catalyst (e.g., CuO, CeO₂) with compressed air at elevated temperatures (150–320°C) and pressures (20–200 bar) can oxidize pharmaceuticals in concentrated waste streams. CWAO is energy-intensive but achieves near-complete mineralization. Advances in catalyst design are lowering the required temperature and pressure.

Advanced Adsorbents: MOFs and Functionalized Silicas

Metal–organic frameworks (MOFs) with tunable pore sizes and functional groups can achieve selective adsorption of specific pharmaceuticals, such as carbamazepine or ibuprofen, with capacities exceeding 500 mg/g. Their chemical stability in water and scalability remain active research areas. Functionalized mesoporous silicas with grafted hydrophobic or chelating groups also show promise for targeted removal.

Regulation and Policy Implications

The European Union's Water Framework Directive and Swiss Federal Act on the Protection of Waters have set legal drivers for pharmaceutical removal at WWTPs. The EU's new Urban Wastewater Treatment Directive (2024 revision) will likely require advanced treatment in larger plants. Similar regulations are emerging in Japan, South Korea, and North America. Chemical techniques, especially ozonation and activated carbon, are listed as Best Available Techniques (BAT). Compliance will drive further investments in chemical treatment infrastructure and monitoring.

Internally, the World Health Organization has provided risk-based guidance on pharmaceuticals in drinking water, while the US EPA continues to develop analytical methods for PPCPs. The Society of Environmental Toxicology and Chemistry has published important frameworks linking chemical treatment efficacy to ecological risk reduction.

Conclusion: A Multi-Barrier Approach Is Essential

No single chemical technique is a universal solution for removing all pharmaceuticals from wastewater. The most reliable and sustainable approach combines multiple chemical methods (e.g., pre-ozonation + activated carbon) with biological and physical steps to create a robust multi-barrier treatment train. As research progresses, new materials and energy-driven processes will lower costs and environmental footprints. However, the immediate priority is to retrofit existing treatment plants with proven chemical technologies—especially ozonation and granular activated carbon—to begin closing the loop on pharmaceutical pollution. Stakeholders from regulators, utilities, and the pharmaceutical industry must collaborate to advance these solutions and protect water quality for generations to come.

Key Takeaways

  • Pharmaceuticals are persistent contaminants requiring chemical oxidation or adsorption for effective removal.
  • Advanced oxidation processes (ozonation, Fenton, photocatalysis) provide the highest destruction efficiency but can generate toxic by-products.
  • Adsorption on activated carbon is robust and widely used, but regeneration creates secondary waste streams.
  • Hybrid systems combining chemical with biological/membrane treatment are most cost-effective for large-scale application.
  • Regulatory frameworks are driving global adoption of chemical treatment in municipal and hospital wastewater management.

For further reading on analytical methods and monitoring of pharmaceuticals in wastewater, consult the ScienceDirect topic collection and the IWA Publishing book Pharmaceuticals in the Environment.